Loading…

Olmesartan-Induced Enteropathy

Olmesartan-induced enteropathy mimics celiac disease clinically and pathologically. As in celiac disease, the pathologic findings are villous atrophy and increased intraepithelial lymphocytes. Clinical presentation of olmesartan-induced enteropathy includes diarrhea, weight loss, and nausea. In cont...

Full description

Saved in:
Bibliographic Details
Published in:Methodist DeBakey cardiovascular journal 2016-10, Vol.12 (4), p.230-232
Main Authors: Adike, Abimbola, Corral, Juan, Rybnicek, David, Sussman, Daniel, Shah, Samir, Quigley, Eamonn
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Olmesartan-induced enteropathy mimics celiac disease clinically and pathologically. As in celiac disease, the pathologic findings are villous atrophy and increased intraepithelial lymphocytes. Clinical presentation of olmesartan-induced enteropathy includes diarrhea, weight loss, and nausea. In contrast to celiac disease, tissue transglutaminase is not elevated and there is no response to a gluten-free diet. Including this entity in the differential diagnosis of sprue-like enteropathy is critical for its early diagnosis since replacing olmesartan with an alternative antihypertensive drug can simplify the diagnostic workup and provide both clinical and histologic improvement.
ISSN:1947-6094
1947-6108
DOI:10.14797/mdcj-12-4-230